Dr Reddy’s recalls over 3.3 lakh bottles of generic medication in U.S.: USFDA

The recall is due to the “presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit”; the affected lot has been produced in India

​The recall is due to the “presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit”; the affected lot has been produced in India